Editorial: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases – the longer the less? Authors' reply
Publication date
2022-01
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Gastroenterology, Pharmacology (medical), Hepatology, Editorial
Citation
Schultheiss, J P D, Mahmoud, R, Fidder, H H & Oldenburg, B 2022, 'Editorial: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases – the longer the less? Authors' reply', Alimentary Pharmacology & Therapeutics, vol. 55, no. 2, pp. 246-246. https://doi.org/10.1111/apt.16722